Suppr超能文献

脑膜瘤切除术后的立体定向放射外科治疗:进展的预测因素

Stereotactic radiosurgery of meningiomas following resection: predictors of progression.

作者信息

Przybylowski Colin J, Raper Daniel M S, Starke Robert M, Xu Zhiyuan, Liu Kenneth C, Sheehan Jason P

机构信息

Department of Neurosurgery, University of Virginia Health System, 1215 Lee Street, Charlottesville, VA 22903, USA.

Department of Neurosurgery, University of Virginia Health System, 1215 Lee Street, Charlottesville, VA 22903, USA; Department of Radiation Oncology, University of Virginia Health System, Charlottesville, VA, USA.

出版信息

J Clin Neurosci. 2015 Jan;22(1):161-5. doi: 10.1016/j.jocn.2014.07.028. Epub 2014 Nov 7.

Abstract

Residual or recurrent meningiomas after initial surgical resection are commonly treated with stereotactic radiosurgery (SRS), but progression of these tumors following radiosurgery is difficult to predict. We performed a retrospective review of 60 consecutive patients who underwent resection and subsequent Gamma Knife (Elekta AB, Stockholm, Sweden) radiosurgery for residual or recurrent meningiomas at our institution from 2001-2012. Patients were subdivided by Simpson resection grade and World Health Organization (WHO) grade. Cox multivariate regression and Kaplan-Meier analyses were performed to assess risk of tumor progression. There were 45 men (75%) and 15 women (25%) with a median age of 56.8 years (range 26.5-82 years). The median follow-up period was 34.9 months (range 6-108.4 months). Simpson grade 1-3 resection was achieved in 17 patients (28.3%) and grade 4 resection in 43 patients (71.7%). Thirty-four tumors (56.7%) were WHO grade 1, and 22 (36.7%) were WHO grade 2-3. Time from resection to SRS was significantly shorter in patients with Simpson grade 4 resection compared to grade 1-3 resection (p<0.01), but did not differ by WHO grade (p=0.17). Post-SRS complications occurred in five patients (8.3%). Overall, 19 patients (31.7%) experienced progression at a median of 15.3 months (range 1.2-61.4 months). Maximum tumor diameter >2.5 cm at the time of SRS (p=0.02) and increasing WHO grade (p<0.01) were predictive of progression in multivariate analysis. Simpson resection grade did not affect progression-free survival (p=0.90). The mortality rate over the study period was 8.3%. SRS offers effective tumor control for residual or recurrent meningiomas following resection, especially for small benign tumors.

摘要

初次手术切除后残留或复发的脑膜瘤通常采用立体定向放射外科治疗(SRS),但放射外科治疗后这些肿瘤的进展难以预测。我们对2001年至2012年在我院接受残留或复发性脑膜瘤切除及后续伽玛刀(瑞典斯德哥尔摩Elekta AB公司)放射外科治疗的60例连续患者进行了回顾性研究。患者按辛普森切除分级和世界卫生组织(WHO)分级进行细分。进行Cox多因素回归分析和Kaplan-Meier分析以评估肿瘤进展风险。共有45名男性(75%)和15名女性(25%),中位年龄为56.8岁(范围26.5 - 82岁)。中位随访期为34.9个月(范围6 - 108.4个月)。17例患者(28.3%)实现了辛普森1 - 3级切除,43例患者(71.7%)实现了4级切除。34个肿瘤(56.7%)为WHO 1级,22个(36.7%)为WHO 2 - 3级。与1 - 3级切除患者相比,辛普森4级切除患者从切除到SRS的时间明显更短(p<0.01),但在WHO分级方面无差异(p = 0.17)。5例患者(8.3%)发生了SRS后并发症。总体而言,19例患者(31.7%)出现进展,中位时间为15.3个月(范围1.2 - 61.4个月)。多因素分析显示,SRS时肿瘤最大直径>2.5 cm(p = 0.02)和WHO分级增加(p<0.01)可预测进展。辛普森切除分级不影响无进展生存期(p = 0.90)。研究期间的死亡率为8.3%。SRS为切除后残留或复发的脑膜瘤提供了有效的肿瘤控制,尤其是对于小型良性肿瘤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验